Desmopressin (DDAVP) and factor VIII: the tale as viewed from Milan (and Malmö)
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (4) , 622-624
- https://doi.org/10.1046/j.1538-7836.2003.00221.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)Journal of Thrombosis and Haemostasis, 2003
- Desmopressin: Twenty Years AfterThrombosis and Haemostasis, 1997
- DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseThe Journal of Pediatrics, 1983
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Asymptomatic liver disease in haemophiliacs.Journal of Clinical Pathology, 1975
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- A NEW VASOPRESSIN ANALOGUE AND FIBRINOLYSISThe Lancet, 1973
- EFFECTS OF DDAVP, A SYNTHETIC ANALOGUE OF VASOPRESSIN, IN PATIENTS WITH CRANIAL DIABETES INSIPIDUSActa Medica Scandinavica, 1972
- Increase in antihaemophilic globulin activity following infusion of adrenalineThe Journal of Physiology, 1961